Modeling the Molecular Determinants of Induced Anti-Tumor Immune Responses in Mantle Cell Lymphoma

Nathanael S Gray

MALT1 inhibitors for the treatment of chemo-resistant ABC-DLBCL

Non-Hodgkin lymphoma

Hematology and hematologic malignancies

Suzanne McGoldrick

Burkitt Lymphoma Clinical Care Project

Non-Hodgkin lymphoma

Hematology and hematologic malignancies

Dean W Felsher

Prognostic Metabolic Signatures of Cancers Through Mass Spectrometry Imaging

Non-Hodgkin lymphoma

Hematology and hematologic malignancies

Eric M Wohlford

The interaction of Burkitt's lymphoma Cofactors EBV and Plasmodium

Non-Hodgkin lymphoma

Hematology and hematologic malignancies Pathology Pediatric oncology or childhood cancer

Andrew Quon

FLT-PET/CT for Therapy Monitoring of DLBCL

Non-Hodgkin lymphoma

Radiation Oncology

Margaret A Goodell

A Mouse Model of DNMT3A-Associated Hematologic Malignancy

Non-Hodgkin lymphoma Leukaemia Hodgkin lymphoma

Carol Prives

Roles and Regulation of p53

Non-Hodgkin lymphoma Breast Bladder

Becca Asquith

KIR in adaptive immunity: in vivo relevance for human disease

Non-Hodgkin lymphoma Leukaemia Hodgkin lymphoma

Hematology and hematologic malignancies

Robert W. Coombs

Laboratory Center, AIDS Clinical Trials Group (ACTG); LC 2 / 3

Trachea, bronchus and lung Other pharynx Oesophagus Non-Hodgkin lymphoma Nasopharynx Liver and intrahepatic bile ducts Kidney, renal pelvis and ureter Kaposi sarcoma Hodgkin lymphoma Colorectum Cervix uteri